In allergic disease, epithelial barrier disruption leads to production of innate cytokines such as IL-33 that skew DC phenotypes and activate innate immune cells (e.g., ILC2s, mast cells, and basophils), thereby eventually promoting the development of Th2 cell that secrete IL-4, IL-5, and IL-13. This evidence concerns the gene IL33 and allergic disease.